Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-14 · accession 0000898432-25-000191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-03-17 | 2025-03-14 | AMRX | Patel Tushar Bhikhubhai | 10% | S - Sale | $8.35 | -5.00M | 48.58M | -9% | -$41.75M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-14 | S | D | 5,000,000 | $8.35 | 48,578,209 | I By a Limited Liability Company Controlled by a Family Trust | — | — |